Phase II Clinical and Correlative Study of Carfilzomib, Lenalidomide, and Dexamethasone (CRd) in Newly Diagnosed Multiple Myeloma (MM) Patients
Year: 2012
Type: article
Source: Blood
Authors: Neha Korde, Adriana Zingone, Mary Kwok, Elisabet E. Manasanch, Rene Costello, Diamond Zuchlinski, Marcia Mulquin, Irina Maric, Katherine R Calvo, Raul C. Braylan, Constance Yuan, Prashant Ramesh Tembhare, Maryalice Stetler-Stevenson, Diane C Arthur, Mark Raffeld, Liqiang Xi, Peter Choyke, Karen Kurdziel, Liza Lindenberg, Seth M. Steinberg, Mark Roschewski, Ola Landgren
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2562471572